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Biocompatibility is a requirement for the development of nanoﬁbers for ophthalmic applications. In this study, nanoﬁbers were elaborated 
using poly(e-caprolactone) via electrospinning. The ocular biocompati- bility of this material was investigated. MIO-M1 and ARPE-19 cell 
cultures were incubated with nanoﬁ- bers and cellular responses were monitored by viability and morphology. The in vitro biocompatibility 
revealed that the nanoﬁbers were not cytotoxic to the ocular cells. These cells exposed to the nanoﬁbers proliferated and formed an 
organized monolayer. ARPE-19 and MIO-M1 cells were capable of expressing GFAP, respectively, demonstrating their functionality. 
Nanoﬁbers were inserted into the vitreous cavity of the rat’s eye for 10 days and the in vivo biocompatibility was investigated using Optical 
Coherence Tomography (OCT), histology and measuring the expression ofpro-inﬂammatory genes (IL-1b, TNF-a, VEGF and iNOS) (real-
time PCR). The OCT and the histological analyzes exhibited the preserved architecture of the tissues of the eye. The biomaterial did not elicit 
an inﬂammatory reaction and pro- inﬂammatory cytokines were not expressed by the retinal cells, and the other posterior tissues of the eye. 
Results from the biocompatibility studies indicated that the nanoﬁbers exhibited a high degree of cellular biocompatibility and short-
term intraocular tolerance, indicating that they might be applied as drug carrier for ophthalmic use. 
 
1. Introduction 
Electrospinning is prevailing as the most convenient method for the fabrication of polymeric nanoﬁbers. In the 
electrospinning pro- cess, the polymer solution is extruded from a nozzle to which ahigh electric voltage is applied (Reneker 
et al., 2000; Ishii et al., 2009). The extruded polymer solution is scattered by the repulsion of electrical charges accumulated 
at the surface of the solution. Then the droplets of the solution are elongated by the electrostatic force operating between 
droplet and substrate. The nanoﬁber is formed by the rapid evaporation of solvent from the droplet (Ishii et al., 2009). 
Nanostructured materials exhibit distinctive and appealing characteristics compared to the bulk material due to small 
dimen- sions and large surface to volume ratio (Moriarty, 2001; Touseef et al., 2013). Additionally, the electrospun ﬁbers 
present a high porosity and interconnected porous network. The characteristics of the nanoﬁbers represent advantages of 
these biomaterials, which provide their applicability in a variety of biomedical ﬁelds. 
Nanostructured scaffolds have been evaluated to study the adhesion, proliferation, and differentiation of different types of 
cells for functional tissue regeneration. These scaffolds should mimic the native extracellular matrix (EMC), providing not only 
the anchorage, growth, and functionalization of the cells, but also the efﬂux of metabolic products produced by those cells. 
Nowadays, the nanostructured cell supports have been applied in tissue engineering of bone (Shabani et al., 2014; Kocabey 
et al., 2013), cartilage (Buchtová et al., 2013; He et al., 2013), nerves (Subramanian et al., 2012; Du et al., 2014), blood 
vessels (Wang et al., 2013; Huang et al., 2013), among others. Besides the applica- tion as cellular carriers, polymeric 
nanoﬁbers incorporated into principle actives have been investigated as delivery systems for releasing drugs over a long 
period of time for the treatment of dif- ferent pathologies.Anti-inﬂammatory agents (e.g., dexametha- sone) (Su et al., 2012), 
antibiotics (e.g., ampicillin, doxycycline) (Sohrabi et al., 2013; Chaturvedi et al., 2013), antitumor drugs (e.g., doxorubicin) Liu 
et al., 2014 represent some examples of therapeutic agents which were encapsulated and/or embedded into the nanometric 
ﬁbers and were sustained released from them. The nanostructured drug delivery systems enable the increase of 
bioavailability of active agents of unfavorable physical and chemi- cal characteristics, assuring an effective therapy (Son et 
al., 2014). 
In the ﬁeld of the ophthalmology, the polymeric nanostructured materials have been evaluated as ocular cellular carrier for 
the treatment of severe pathologies, which can lead to impaired vision and/or blindness. For example, a 3D polyamide 6/12 
nanoﬁber scaffold was applied as support for the growth and proliferation of mesenchymal and limbal stem cells for their 
transplantation and reconstitution of a mechanically damaged corneal surface in an experimental mouse model (Holan et al., 
2013). The human cor- neal epithelial cell line was used to evaluate the biocompatibility of electrospun poly(e-
caprolactone) nanoﬁbers. It was veriﬁed that the nanoﬁbers provided not only a milieu supporting the corneal epithelial cells 
expansion, but also serve as a useful alternative car- rier for ocular surface tissue engineering and could be used as an 
alternative substrate to replace human amniotic membrane (HAM)Sharma et al., 2011. 
Before the clinical application of the nanostructured materials in the reconstitution of damage tissues and organs, the 
biocom- patibility of these biomaterials must be extensively investigated. The biocompatibility studies of the potentially 
nanostructured scaffolds should involve laboratory and animal experiments which allows to determine their biological safety. 
Regarding the impor- tance of evaluating the biological safety of electrospun poly(e- caprolactone) nanoﬁbers, in this study, 
the in vitro and in vivo bio- compatibility of these nanostructured polymeric material was investigated to consider their 
suitability for ophthalmic applica- tions. The in vitro biocompatibility of the poly(e-caprolactone) nanoﬁbers was analyzed 
using Müller glial cells (MIO-M1) and retinal pigment epithelial cells(ARPE-19) cultures. The response of the ocular cells in 
direct contact with the nanoﬁbers was 
determined in terms of viability and capacity to proliferate and dif- ferentiate. The in vivo biocompatibility of the nanoﬁbers 
was ana- lyzed after their implantation in the vitreous cavity of the rat’s eye using the OCT, histology and the measurement 
of the expression ofpro-inﬂammatory genes (real-time PCR). The ophthalmic applica- tion of the poly(e-
caprolactone) nanoﬁbers depends on their intraocular biocompatibility, without eliciting inﬂammatory and immune responses 
or toxic reactions. 
2. Materials and methods 
2.1. Preparation of the poly(e-caprolactone) nanoﬁbers – electrospun nanoﬁbers 
Poly(e-caprolactone) (PCL, MW  80,000–90,000 g/mol; Sigma Chemical Co., USA) solution [14.6% (w/v)] was prepared 
by dissolv- ing PCL pellets in a mixture of acetic acid and formic acid (1:1) (Sigma Aldrich, St. Louis, MO), under magnetic 
stirring for 3 h at room temperature. The clear solution was electrospunusing an electrospinning setup consisting of a dual 
polarity, high-voltage DC power supply unit (Gamma High Voltage Research, Ormond Beach, FL), a syringe pump (Arti 
Glass, CE, Italy), syringe (Dispovan, Faridabad, India), and a needle (24 G) with blunted tip. The positive terminal of 
the high-voltage supply was connected to the needle tip while the negative terminal was connected to a metallic collector 
plate; a voltage of +25 kV was maintained between them. Electrospun ﬁbers were collected on coverslips kept over the 
metallic collector disc (8 cm of diameter). Flow rate was maintained at 3.6 mL/h and needle tip to collector distance was 
maintained at 9 cm. 
2.2. Morphology and diameter of the PCL nanoﬁbers 
Morphology and diameter of the PCL nanoﬁbers were analyzed by scanning electron microscopy (SEM) (JEOL JSM 
5600, Japan) at an accelerating voltage of 15 kV. Samples for SEM were mounted on metal stubs and coated with gold using 
a sputter coater (JEOLJFC-1200 ﬁne coater, Japan). Non-woven nanoﬁber mats were ana- lyzed with 50 individual 
measurements of nanoﬁber diameters taken from SEM micrographs using image analysis software (Image J, National 
Institutes of Health, USA). This was repeated for a single electrospun ﬁber mat fabricated under a sing le set of constant 
conditions to calculate the average nanoﬁber diameter and standard deviation. 
2.3. In vitro biocompatibility study 
2.3.1. ARPE-19 and Müller glial cell (MIO-M1 cell) cultures 
ARPE-19 cells, an established but non-immortalized human RPE cell line, were graciously provided by Dr. Hjelmeland 
(University of California, Davis, CA) and were grown in a Dulbecco’s modiﬁed eagles medium and Ham’s F12 medium 
(DMEM/F12 Gibco BRL: Grand Island, NY) with 10% fetal bovine serum (FBS Gibco BRL: Grand Island, NY) in a 37 LC 
humidiﬁed atmosphere of 5% CO2 and 95% air.  
Müller glial cells (MIO-M1 cells), a spontaneously immortalized RMG cell line originated from human retina (Limb et al., 
2002), were kindly provided by Dr. Astrid Limb (University College London, London, UK) and were grown in a Dulbecco’s 
modiﬁed eagles medium/glutamax (DMEM/glutamaxGibco BRL: Grand Island, NY) with 10% fetal bovine serum (FBS Gibco 
BRL: Grand Island, NY), 0.4% gentamicin, and 0.1% amphotericin B at 37 LC in a humidiﬁed atmosphere of 5% CO2 and 
95% air. 
The culture medium of both cells was refreshed every 2 days. Upon conﬂuence, cells were rinsed with 2 mL of a 0.05% 
trypsin-EDTA (Gibco, Grand Island, NY) solution and incubated with 5 mL of trypsin-EDTA at 37 LC in a humidiﬁed 
atmosphere of 5% CO2 and 95% air. Next, within 5–15 min, the trypsin enzyme activity was stopped by the addition of 5 mL 
of complete growth medium and centrifuged for 5 min at 1500 rpm. The supernatant was discarded, while the cells were 
resuspended in 13 mL of fresh medium and seeded onto culture ﬂasks for further propagation and subsequent passages. 
2.3.2. ARPE-19 and MIO-M1 cell cultures in contact with PCL nanoﬁbers 
The PCL nanoﬁbers were cut into round pieces (4.5 mm in diameter, average weight of 0.12 mg ± 0.09 and n = 10), and 
disin- fected by exposure to UV light for 90 min on each side prior to cell culture. ARPE-19 and MIO-M1 cells were plated in 
contact of the 103 cells/well. 
2.3.3.ARPE-19 and MIO-M1 cell proliferation in contact with PCL nanoﬁbers (nuclear count) 
After 1, 2, 5 and 10 days in the culture, the medium was aspi- rated, and the ARPE-19 and MIO-M1 cells in contact with 
PCL nanoﬁbers and control TCPS were rinsed with phosphate-bufferedsaline (PBS) and ﬁxed in paraformaldehyde 4% (v/v) 
(Merck Eurolab, Fontelay Sous-Bois, France) for 15 min. Next, ﬁxed cells were rinsed again with PBS for 5 min and 
immersed in PBS con- taining 0.3% (v/v) Triton X-100 (Sigma- Aldrich) for 15 min. After rising in PBS for 5 min, the nuclei 
were stained with 40,6-diami-dino-2-phenylindole (DAPI) (Sigma-Aldrich) in PBS (1:1250) for 5 min at room temperature. 
Finally, the cells were washed ﬁve times at 5 min intervals with PBS and one time with water, mounted in Gel Mount 
(Biomeda, Burlingame, CA) and viewed using an Olympus IX70 ﬂuorescent microscope attached to a digi- tal camera 
(Olympus DP70). Five ﬁelds were photographed per PCL 
nanoﬁbers and control TCPS (total of 15 ﬁelds per surface per time- point). The nuclei were counted for each ﬁeld of view 
(0.59 mm2). The average number of nuclei on the control surface was set as 100%, while the average number of nuclei ± 
standard deviation in contact with PCL nanoﬁbers was obtained as a percentage of the control. Data were presented as a 
histogram. 
2.3.4.Cytotoxicity of the PCL nanoﬁbers 
After 1, 2, 5 and 10 days in the culture, the medium was aspi- rated, and the ARPE-19 and MIO-M1 cells in contact with 
PCL nanoﬁbers and control TCPS were rinsed with phosphate-bufferedsaline (PBS). The ARPE-19 and MIO-M1 cells were 
incubated with 150 lL of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltertrazoliumbromide (MTT) (1 mg/mL in PBS) (Sigma 
Chemical, Saint Louis, CO). After 3 h of incubation, the cells were lysed with 100 lL of iso- propanol, and absorbance values 
were measured at 570 nm versus 630 nm using a microplate reader (BioRad, San Diego, CA). The mean absorbance on the 
control surface was set as 100%, while the mean absorbance ± standard deviation in contact with PCL nanoﬁbers was 
obtained as a percentage of the control. Data were presented as a histogram. 
2.3.5. Morphology of the ARPE-19 and MIO-M1 cells – Immunoﬂuorescence 
At 10 days of culture, the ARPE-19 and MIO-M1 cells in contact with PCL nanoﬁbers and control TCPS were submitted to 
the same procedure described for the proliferation study. After nuclei stain- ing with DAPI, F-actin ﬁbers were labeled with 
Phalloidin FITC(Sigma-Aldrich) in PBS (1:250) for 30 min at room temperature. Cells were then rinsed, mounted, and viewed 
using Olympus 
IX70 ﬂuorescent microscope attached to a digital camera (Olympus DP70). 
At 10 days of culture, for the labelling of occludin tight junc- tions, the ARPE-19 cells grown in contact with PCL 
nanoﬁbers and control TCPS were ﬁxed with p-formaldehyde 4% (v/v) for 30 min at room temperature. The ﬁxed cells were 
incubated with PBS containing Triton X-1000.1% (v/v) for 30 min. This was fol- lowed by incubation with the rabbit anti-
Occludin (Zymed Laboratories, South San Francisco, CA) in PBS containing Triton X- 1000.1% (v/v) (1:100) for 60 min. The 
cells were rinsed twice with PBS for 10 min and incubated with an Alexa Fluor 488 goat anti- rabbit secondary antibody 
(Molecular Probes) in PBS (1:250) for 60 min in the dark. Finally, cells were rinsed, mounted, and viewed using Olympus 
IX70 ﬂuorescent microscope attached to a digital camera (Olympus DP70). 
At 10 days of culture, for the labelling of glial ﬁbrillary acidic protein (GFAP), the MIO-M1 cells grown in contact with PCL 
nano- ﬁbers and control TCPS were ﬁxed with p-formaldehyde 4% (v/v) for 30 min at room temperature. The ﬁxed cells were 
incubated with PBS containing Triton X-100 0.1% (v/v) for 30 min. This was followed by incubation with polyclonal rabbit 
antibody against GFAP (1:100) (Dako, Trappes, France) at room temperature for 3 h. After washing with PBS, an Alexa 
Fluor 488-conjugated goat anti-rabbit IgG (1:100) (Molecular Probes, Leiden, The Netherlands) was applied for 60 min in the 
dark. Finally, the nuclei were stained with DAPI (Sigma-Aldrich)in PBS (1:1250) for 5 min at room temperature. Then, the 
cells were rinsed ﬁve times, mounted, and viewed using Olympus IX70 ﬂuorescent microscope attached to a digital camera 
(Olympus DP70). 
2.4. In vivo biocompatibility study 
2.4.1. Animals 
Female Lewis rats (8–12 weeks old; Janvier, Le Genest-Saint-Isle, France) were kept in pathogen free conditions with 
food and water ad libitum and housed in a 12-h light/12-h dark cycle. The animals were divided into two groups: (1) rats 
without PCL nano- ﬁbers (control group); (2) rats receiving PCL nanoﬁbers into the vitreous cavity. For each experimental 
series, the number of ani- mals was indicated in the ﬁgure legends. All experiments were per- formed in accordance with the 
European Community’s Council Directive 86/609/EEC and approved by ethical committees of the Université René 
Descartes. 
2.4.2. Insertion of the PCL nanoﬁbers into the vitreous cavity 
PCL nanoﬁbers of 1 mm of ray were sterilized as previously described. The animals were anaesthetized with an 
intraperitoneal injection of xylazine (20 mg/kg) and ketamine (80 mg/kg). The left pupil was dilated with tropicamide eye 
drops (Johnson & Johnson Vision Care, USA). To implant the PCL nanoﬁbers into the vitreous cavity, the conjunctiva was 
dissected at the limbus in the temporo- superior quadrant and a 1 mm scleratomy was performed at 2 mm posterior to the 
limbus. The PCL nanoﬁbers were introduced into the vitreous cavity through a trans-choroid way. 
2.4.3. Optical Coherence Tomography (OCT) 
In vivo assessment of rat’s choroid and retina was performed on anesthetized animals using spectral domain Optical 
Coherence Tomography (OCT) (SD-OCT; Spectralis device) adapted for small animal eyes (Fischer et al., 2009). Pupils 
were dilated with 5% tropicamide drops (Théa). Scans were taken after 10 days of inser- tion of the PCL nanoﬁbers into the 
vitreous cavity of rat’s eye. The rats of the control group were submitted to the same OCT evalua- tion. The temporal, nasal, 
and superior quadrants of the retina were analyzed, using the optic nerve head and the retina vessels as landmarks. Each 2-
dimensional B-scan recorded at 30L ﬁeld of view consisted of 1,536 A-scans with an optical resolution reaching 3.5 lm, and 
the enhanced depth imaging option was used to evalu- ate the choroid and retina. Retinal layers and choroid thickness was 
measured manually every 100 lm from the peripheral to the posterior pole. For analysis, the retina and choroid was divided 
into 3 zones: periphery, middle, and posterior pole. In the middle sec- tion, 3-4individual measurements were performed per 
rat (n = 5 per group). 
2.4.4. Morphology 
Animals of both groups were sacriﬁced using a lethal dose of pentobarbital (100 mg/kg – intraperitoneal injection) at 10 
days of the experiment. Enucleated eyes were ﬁxed in glutaraldehyde 2.5% (v/v) in cacodylate buffer (0.1 mol/L, pH 7.4). 
After 5 h of ﬁxa- tion, the eyes were dehydrated in a graded alcohol series (50%, 70%, 95%, and 100%) and embedded in 
epoxy resin. Semi thin sections (1 lm) were cut using an ultramicrotome (Reichert Ultracut E, Leica, Wetzlar, Germany) and 
stained with toluidine blue. The mor- phology was examined under a light microscope (Olympus IX70) attached to a digital 
camera. Retinal layers and choroid thickness was measured manually every 100 lm from the peripheral to the posterior pole. 
For analysis, the retina and choroid was divided into 3 zones: periphery, middle, and posterior pole. In the middle sec- 
tion, 3–4 individual measurements were performed per rat (n = 3 per group). 
2.4.5. Immunoﬂuorescence 
Enucleated eyes were ﬁxed in paraformaldehyde 4% (v/v) for 30 min and incubated with a graded series of sucrose 
before being snap frozen in Tissue-Tek OCT-compound (Bayer Diagnostics, Puteaux, France). Ten micrometer cryostat 
sections of rat eyes were obtained. Unspeciﬁc binding sites were blocked with 5% nor- mal goat serum for 1 h. The sections 
were then incubated with pri- mary antibody mouse rabbit anti-ionized calcium binding adaptormolecule-1 (anti-IBA-1, 1:400, 
Wako, Richmond, USA). After wash- ing, slides were stained for 5 min with DAPI and washed again. The second antibodies 
was Alexa Fluor 488-coupled goat anti-rabbit IgG (1:200, Invitrogen). Negative controls were performed by omission of 
primary antibody. Four eyes from 4 rats per group and 4 sections per eye were analyzed. 
2.4.6. Reverse transcription and real-time PCR 
Animals of both groups were sacriﬁced using a lethal dose of pentobarbital (100 mg/kg – intraperitoneal injection) at 10 
days of the experiment. Enucleated eyes were dissected at the level of the limbus and lens removed. The retina and 
posterior part of the eye were frozen and stored at 80 LC for preservation. Total RNA was isolated from the retina and 
posterior part of the eye using RNeasy Mini Kit (Qiagen, Courtaboeuf, France). First-strand cDNA was synthesized after 
DNase I (Qiagen) treatment using ran- dom primers (Invitrogen) and superscript II reverse transcriptase (Invitrogen). 
Transcript levels of TNF-a, IL1b, VEGF and iNOS were analyzed by real-time PCR performed in 7500 Real-Time PCR 
System (Applied Biosystems, Foster City, CA, USA) with either TaqMan (Applied Biosystems) or SYBR Green (Invitrogen) 
detec- tion. The 18S gene was used as internal control. Table 1 shows the references or sequences of primers used for both 
techniques.Delta-delta cycle threshold calculation (Ouvrard-Pascaud et al., 2005) was used for relative quantiﬁcation of 
results. 
2.5. Statistical analysis 
Results were expressed as mean ± standard deviation. Data were tested for normality and investigated for statistical signiﬁ- 
cance using the Student´s t test and one-way analysis of variance (ANOVA), where appropriate. A P-value of less than 0.05 
was con- sidered signiﬁcant. 
 
 
Table 1 
Real-time PCR primers and probes. 
Gene TaqMan probe reference or SYBR Green primer 
18S Human Hs99999901_s1a 
18S Human and rat Sense 50 -TGCAATTATTCCCCATGAACG-30 
  
Antisense 50 -GCTTATGACCCGCACTTACTGG-3 
HPRT1 Rn01527840_m1 
HPRT1 Sense 50 -GCGAAAGTGGAAAAGCCAAGT-30 
  
Antisense 50 -GCCACATCAACAGGACTCTTGTAG-30 
TNF-a 
Rn01525859-
g1 
  
IL1b Rn00676333_g1 
iNOS Sense 50 -CTC GG A GGT CCA CCT CAC TGT-30 
  
Antisense 50 -GGT TAT TGA TCC AAG TGC TGC-30 
a Patent of TaqMan . Sequence is not available. 
3. Results 
3.1. Morphology and diameter of the PCL nanoﬁbers 
Fig. 1 represented the SEM image of the PCL nanoﬁbers. The electrospinning process provided the deposition of 
interconnected ﬁbers. This nanometric three-dimensional network presented high porosity. Finally, the average ﬁber diameter 
was 130 ± 62 nm. 
3.2. In vitro biocompatibility study 
3.2.1. ARPE-19 and MIO-M1 cell proliferation in contact with PCL nanoﬁbers (nuclear count) 
The proliferation of ARPE-19 cells in contact with PCL nanoﬁ- bers and control TCPS was expressed as percentage of 
cells in com- parison with the day-1. On days 2, 5 and 10, the percentage of RPE cells in contact with PCL nanoﬁbers and 
control TCPS increased sig- niﬁcantly (Fig. 2A), indicating the proliferative capacity of these ocular cells. Additionally, the 
number of MIO-M1 cells in the pres- ence of the PCL nanoﬁbers and in the control TCPS on days 2, 5 and 10 progressively 
increased (Fig. 2B), demonstrating the growth of these neuroretina cells. Although the number of cells was greater in the 
control TCPS for all time intervals, the statistical analysis (one-way ANOVA) showed that there was no signiﬁcant differ- 
ences in cell proliferation in contact with PCL nanoﬁbers and con- trol TCPS (p < 0.05) after 2, 5, and 10 days of in vitro 
culture. 
 
Fig. 1. SEM photomicrograph – morphology of electrospun PCL nanoﬁbers. 5000magniﬁcation. Scale bar – 30 lm. 
 Fig. 2. Proliferation kinetics of (A) ARPE-19 cells and (B) MIO-M1 cells cultured in direct contact with PCL nanoﬁbers and control TCPS at 1, 2, 5 and 
10 days of incubation. Data were expressed as mean number of nuclei ± standard deviation for each time-point (n = 10 per group, per day) (p < 0.05). 
3.2.2. Cytotoxicity of the PCL nanoﬁbers 
Fig. 3 demonstrated the viability of ARPE-19 and MIO-M1cellscultured in contact with PCL nanoﬁbers and control 
medium. The viability of the ocular cells was evaluated at 2, 5 and 10 days of incubation. Accordingly, the polymeric 
nanoﬁber and its degrada- tion products showed to be no toxic to RPE and MIO-M1 cells, since there were no signiﬁcant 
differences on the viabilities of these ocu- lar cells in all medium (control and treated groups) (one-way ANOVA, p < 0.05). It 
was suggested that the PCL nanoﬁber and its possibleby-products did not present cytotoxic effects against ARPE-
19 andMIO-M1 cells in vitro cultured. 
3.2.3. Morphology of the ARPE-19 and MIO-M1 cells – Immunoﬂuorescence 
The morphology of the ARPE-19 and MIO-M1 cells was evalu- ated after 10 days of seeding in direct contact with the 
PCL nanoﬁ- bers. The RPE cells (Fig. 4A) reached a conﬂuent level and a high cell density was evidenced. Staining of actin 
ﬁbers in the cytoskele- ton revealed a highly interconnected cell network, since the actin ﬁlaments were running parallel to 
one another through the upper part of the cytoplasm, and being inserted into the intercellular membrane of adjacent cells, 
thus providing a connection between them (Silva et al., 2011). Staining of cell nuclei indicated that they were centrally 
located and did not appear to overlap, suggesting a monolayer formation. Additionally, these ARPE-19 cells were cap- able 
of expressing the occludin (Fig. 4B), demonstrating their func- tionality. The occludin is a transmembrane tight junction 
protein involved in theblood-retinal barrier. This barrier prevents the dif- fusion of solutes through the neuroretina (Tsukita et 
al., 1991). Therefore, the PCL nanoﬁbers did not downregulate the expression of this tight junction protein. 
The MIO-M1 cells, cultured in the presence of the PCL nanoﬁ- bers, showed typical morphological features. The Müller 
glial cells (Fig. 4C) reached conﬂuence on the glass coverslips. These retinal cells expressed the microﬁlament actin, 
revealing the existence of elongated and radially oriented cells. The nuclei were ellipsoid and highly centralized. The MIO-
M1 cells demonstrated their abil- ity to express the glial ﬁbrillary acidic protein (GFAP) (Fig. 4D) similarly to the control cells. 
GFAP is a ubiquitous marker for glia and an important cytoskeletal component determining cell mor- phology(Shao-Fen et 
al., 2013). Finally, the PCL nanoﬁbers did not interfere in the expression of the GFAP; therefore the bio- material did not 
promote detectable modiﬁcations in the MIO- M1 phenotype. 
3.3. In vivo biocompatibility study 
3.3.1. Optical Coherence Tomography (OCT) 
The in vivo OCT images demonstrated that the PCL nanoﬁber and possible by-products of the PCL in the vitreous cavity 
of the 
rat’s eye did not affected the integrity of the choroid and retinal layers when compared to the control group, which did not 
receive the polymeric nanoﬁbers (Fig. 5A and B, respectively). Moreover, the choroid thickness of both groups of animals 
was measured, and there was no statistically signiﬁcant difference between the thickness of this ocular structure (t-Student, p 
< 0.05) (Fig. 5C). The retinal layers thickness in the middle pole was also measured and the signiﬁcant difference between 
animals receiving PCL nano- ﬁbers and control was not detected (t-Student, p < 0.05) (Fig. 5C). These quantitative data 
corroborated with the qualitative observa- tions using in vivo OCT; and conﬁrmed that the nanobiomaterials did not interfere 
in the choroid and retinal architectures during the follow-upperiod of intravitreal implantation. The OCT images also 
demonstrated that the vitreous cavity did not present hemor- rhages or abnormalities. Finally, the short-term in vivo 
biocompati- bility of the PCL nanoﬁbers and their degradation products could be visualized using the OCT scan of the tissues 
of the posterior seg- ment of the eye. 
3.3.2. Morphology 
PCL nanoﬁbers implanted in the vitreous cavity of the rat’s eye were well tolerated, considering that no clinical evidence 
of immediate or delayed intraocular inﬂammation could be observed (Fig. 6A). Histological examination of the posterior and 
anterior segments of the eye showed that the architecture of the ocular tis- sues was completely preserved after 10 days of 
intravitreal implantation of the PCL nanoﬁbers (Fig. 6B) when compared to the architecture of the segments of the rats of the 
control group (Fig. 6C). No inﬁltration of inﬂammatory cells was observed on any of the ocular sections. Moreover, the 
choroid thickness of both groups of animals was measured and there was no statistically sig- niﬁcant difference between the 
thickness of this ocular structure (t-Student, p < 0.05) (Fig. 6D). The retinal layers thickness in the middle pole was also 
measured and the signiﬁcant difference between animals receiving PCL nanoﬁbers and control was not detected (t-
Student, p < 0.05) (Fig. 6D). Finally, the histological examination corroborated with data obtained in the OCT scans, 
providing information of the in vivo biocompatibility of the PCL nanoﬁbers and the possible degradation products from the 
poly- meric chains. 
3.3.3. Immunoﬂuorescence 
The microglia and macrophage activation was evaluated using theanti-ionized calcium binding adaptor molecule 1 (IBA-
1) after 10 days of insertion of the PCL nanoﬁbers in the vitreous cavity of the rat’s eye. Accordingly, the number of activated 
microglia and macrophage was extremely low in the retina in the presence of the nanometric ﬁbers and in the control group 
(Fig. 7A and B). This result indicated the excellent biocompatibility of the nano- metric ﬁbers since activated microglial cells 
and recruited macrophages are directly implicated in retinal degeneration, probably through the secretion of pro-
inﬂammatory mediators and cytotoxic factors, such as TNF-a, IL-1b, nitric oxide, among others (Rutar et al., 2012). Moreover, 
the number of activated macrophage and microglia in the ciliary body of the eyes of the ani- mals receiving PCL nanoﬁbers 
was insigniﬁcant (Fig. 7C and D), suggesting that the IBA-1 stained only the resident cells; and the nanomaterial did not elicit 
an inﬂammatory response in the ante- rior segment of the eye. 
 
 
Fig. 3. Viability of (A) ARPE-19 and (B) MIO-M1 cells cultured in direct contact with PCL nanoﬁbers and control medium, at 1, 2, 5 and 10 days of 
incubation (n = 10 for each PUD per group, per day) (p < 0.05). The viability of the ocular cells in contact with PCL nanoﬁbers was relative to the 
control, ﬁxed at 100%. 
                                      Fig. 4. 
Micrographs of ARPE-19 and MIO-M1 cells in contact with PCL nanoﬁbers for 10 days. (A) F-actin (green) and nuclei (blue) of ARPE-19 cells stained 
with Phalloidin FITC and DAPI after 10 days of culture (80). (B) Intercellular tight junctions (occludin) (green) between adjacent ARPE-19 cells (80). 
(C) F-actin and nuclei ofMIO-M1 cells stained with Phalloidin FITC and DAPI after 10 days of culture (40). (D) GFAP (red) expressed by Müller glial 
cells (40). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
Fig. 5. In vivo OCT scan of the choroid and retinal layers of the rat’s eye which received PCL nanoﬁbers (A) and the animals of the control group 
(without polymeric implants) 
(B). Choroid and retinal layers thickness of the animals of both groups (p < 0.05) (n = 6 per group) (C). Scale bar – 200 lm. 
 Fig. 6. Well tolerated PCL nanoﬁber in the vitreous cavity of the rat’s eye after 10 days of implantation (A). Toluidine blue stained histological section on 
postoperative day 10 with PCL nanoﬁbers within the vitreous cavity of the rat’s eye (B) and the animals of the control group (without polymeric 
nanoﬁbers) (C) (40). Choroid and retinal layers thickness of the animals of both groups were not statistically different (p < 0.05) (D) (n = 3 per group). 
Retinal layers: RPE – retinal pigment epithelium; ONL – outer nuclear layer; OPL – outer plexiform layer; INL – inner nuclear layer; IPL – inner plexiform 
layer; GCL – ganglion cell layer. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this 
article.)  
 
Fig. 7. Immunoﬂuorescence detection of IBA-1 activated microglia and macrophage (red) in the retina of rat’s eye after receiving PCL nanoﬁbers for 10 
days (A) and in the eyes of the control group (without polymeric nanoﬁbers) (B). The nuclei of retinal cells was stained with DAPI. IBA-1 resident 
macrophage (red) in the ciliary body of the anterior segment of the rat’s eye in the presence of polymeric nanoﬁbers (C) and in the eyes of the control 
group (D). The nuclei of ciliary body cells was stained with DAPI (40). Scale bar – 20 lm. (For interpretation of the references to colour in this ﬁgure 
legend, the reader is referred to the web version of this article.) 
 
3.3.4. Reverse transcription and real-time PCR 
The expression of some pro-inﬂammatory genes (IL-1b, TNF-a,VEGF and iNOS) by retinal cells and cells of the posterior 
part of the eye in direct contact with the PCL nanoﬁbers was measured to verify the capacity of these nanostructured 
materials to induce an inﬂammatory response. Accordingly, the polymeric nanoﬁbers did not signiﬁcantly stimulate the 
expression of the pro-in- ﬂammatory mediators compared to the production of them by the retinal cells and posterior ocular 
cells in the control group (Fig. 8) (t-Student, p < 0.05). Therefore; the PCR results suggested that the PCL nanoﬁbers did not 
change the pattern of expression of some importantpro-inﬂammatory genes by the ocular cells. Finally, data obtained 
from IBA-1 stained were in concordance with the quantitative results obtained from RT-PCR. 
4. Discussion 
In this study, PCL nanoﬁbers were elaborated based on the elec- trospinning technique. The electrospinning 
conﬁguration, the 
operational conditions (applied electric ﬁeld of +25/0 kV; needle-to-collector distance equivalent of 9 cm; ﬂow rate of 3.6 
mL/h) and the solubilization of the PCL in a mixture of acetic acid and for- mic acid (1:1) yield the existence of ultraﬁne 
polymeric ﬁbers. The high dielectric constant of the formic acid (e = 57.5) along with the polyelectrolyte character of the 
formic acid and acetic acid were responsible for a high electrical conductivity, leading to a greater tensile force, which could 
induce to an increase in the stretching and splitting of the jet, resulting in a thinner ﬁber and broader diameter distribution of 
the PCL nanoﬁbers (Meng et al., 2010). 
The PCL nanoﬁber was synthetized aiming the ophthalmic applications. However, the biocompatibility of this nanostructured 
material must be investigated prior to its clinical application. Besides the PCL is a biodegradable and biocompatible polymer, 
the possibility of the existence of solvent residues in the ultraﬁne mats could be toxic to the ocular tissues resulting in the fail 
in the ophthalmic use of these polymeric nanoﬁbers. Any minimum level of toxicity of the solvent residues would be enough 
to cause a severe inﬂammatory response in the posterior segment of the eye, and consequently, to disturb the integrity of the 
neural retina and other tissues of the eye. The disruption of the neural retina eventually results in reduction of the visual 
acuity and/or blind- ness. Therefore, low levels of toxicity would be enough to lower our expectations regarding using the 
developed PCL nanoﬁbers in ophthalmic applications. 
The in vitro biocompatibility of the nanostructured materials was demonstrated using MIO-M1 and ARPE-19 cells. The 
viability of these cells in direct contact with the PLC nanoﬁbers indicated a high survival rate over a period of 10 days in in 
vitro culture con- ditions. It supports the idea that PCL nanoﬁber and its by- products were non-toxic and biocompatible. 
Furthermore, the cells pro- liferated and differentiated in the presence of the ultraﬁne materi- als. TheARPE-19 cells were 
capable of expressing occludin, suggesting the presence of tight junctions among them. The obtained result indicated that 
RPE cells presented cell-cell interac- tions, which is essential for the formation of a functional endothe- lial monolayer (Silva 
et al., 2011). The RPE must adopt a tight epithelial monolayer phenotype, which acts as a blood-retinal bar- rier (Lu et al., 
2007). The MIO-M1cells also demonstrated their functionality in contact with PCL nanoﬁbers, since their endochy- lema 
contained large number of actin ﬁlaments and they produced GFAP similarly to the control cells (without contact with the 
nano- ﬁbers). The similar pattern of GFAP production by the MIO-M1 cells of both groups indicated that cells were not under 
stress, once the up-regulation of GFAP is an early event under retinal stress conditions (Bringmann et al., 2009). 
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Fig. 8. Real-time PCR of pro-inﬂammatory genes (IL-1b, TNF-a, VEGF and iNOS) produced by retinal cells and cells of the posterior part of the eye in 
direct contact with the PCL nanoﬁbers and in the control group. 
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 The in vitro biocompatibility studies demonstrated several encouraging ﬁndings about the electrospun PCL nanoﬁbers in 
the presence of retinal cells. The obtained results were similar of those previously reported by Sharma and co-
workers (Sharma et al., 2011), who showed the biocompatibility of electrospun PCL nano- ﬁbers in contact with human limbal 
epithelial cell line (LEC). The fabricated nanoﬁbers were able to support the attachment and proliferation of viable LEC line. It 
was hypothesized that the trans- plantation of ex-vivo expanded LEC could be a promising proce- dure to treat the 
dysfunction or loss of corneal limbal epithelial cells. On the other hand, in our work; the produced PCL nanoﬁbers were not 
capable of supporting ARPE-19 and MIO-M1 cells, which areanchorage-dependent cells. Our PCL nanoﬁber presented a 3D 
pattern, which closely mimics the extracellular matrix environ- ment of the tissue; and it is required for successful retinal cell 
adhesion and subsequent transplantation (Sharma et al., 2011); however, besides this favorable characteristic, they did not 
pro- mote the adhesion of the ARPE-19 and MIO-M1 cells probably due to the high hydrophobicity of the PCL. It was 
previously docu- mented that the hydrophobicity of the PCL limits the adhesion of cells (Kim and Cho, 2009). The strategies 
to induce the cell adhe- sion and proliferation onto the surface of the PCL nanoﬁbers could be: (1) the incorporation of cell-
recognition domains such as bioac- tive proteins. For example, the collagen exposed on the surface of the nanoﬁbers 
interacts with ﬁbronectin, a glycoprotein, which binds the collagen to the integrin receptor on cell membranes, pro- moting 
cell adhesion onto the surface of the PCL nanoﬁbers (Schnell et al., 2007); (2) the enhancement of the hydrophilicity of the 
surface using plasma treatment. Accordingly, plasma surface treatment of a polymeric matrix with N2, O2 and NH3 makes the 
surface of the matrix more hydrophilic and more bioadhesive (Bakhshandeh et al., 2011); (3) the association of the PCL with 
a hydrophilic polymer forming a blended nanostructured biomateri- al. Polymer blending is one of the most effective methods 
for pro- viding new and desirable biocomposite for particular applications(Ghasemi-Mobarakeh et al., 2008). 
Many of the biomaterials in use as ocular devices have been evaluated through various methodological studies using in 
vitro cell cultures and in vivo animal models. In this study, the in vivo biocompatibility of the PCL nanoﬁber was investigated 
inserting this nanostructured material into the vitreous cavity of rat’s eye; and evaluating the formation of an inﬂammatory 
response. The inﬂammation is characterized by various important events includ- ing the recruitment of inﬂammatory cells as 
well as the injury- induced degranulation of resident mast cells. Then, local immune cells, including resident macrophages, 
are activated by proin- ﬂammatory mediators released in response to injury. In response to these many signals, the levels of 
leukocyte chemoattractants increase substantially, further enhancing leukocyte recruitment to the tissue. The neutrophils are 
the dominant leukocyte in the earliest stages of the inﬂammatory response. Concomitantly with the inﬂux of neutrophils, 
circulating monocytes enter the wound and differentiate into mature tissue macrophages (Koh and DiPietro, 2011). If the 
inﬂammation does not resolve, the number of inﬂammatory cells increases, promoting severe damages to the affected tissue. 
The histological assessment of the ocular tissues after exposition to the PCL nanoﬁber and its degradation products 
demonstrated that they did not elicit an inﬂammatory reaction, since inﬁltrated inﬂammatory cells were not observed, and vitr- 
eous and/or choroidal hemorrhage and retinal detachment were not detected, resulting in the preservation of the integrity of 
the sensible visual structures of the posterior segment of the eye. The obtained results were similar of those previously 
described by Bernards and co-workers (Bernards et al., 2013), who demon- strated that micro and nanostructured PCL thin 
ﬁlms exhibited acceptable ocular tolerance, once histological evaluation showed no inﬂammation or morphologic 
abnormalities at the ocular sites, including the cornea and anterior segment, trabecular meshwork, retina, uvea and vitreous. 
The limitation of this study was the incomplete physical degradation of the micro and nano polymeric devices during the 6-
month implantation period with minimal gross breakdown observed ophthalmoscopically. 
The OCT images can identify and quantify the retinal and chor- oidal thickness changes in vivo without enucleation. The 
existence of an intraocular inﬂammation resulted from a toxic effect of a bio- material could be clearly detected by the OCT 
images as a signiﬁ- cant modiﬁcation in retinal and choroidal thickness (Hwang et al., 2013). In this study, the OCT 
examination demonstrated that the PCL nanoﬁbers did not provoke an inﬂammatory reaction and the thickness of the retina 
and choroid were comparable to the thickness of those structures in the eyes of the animals of the con- trol group. 
Considering that the architecture of the retina was pre- served, it could be suggested that there was no photoreceptor 
degeneration caused by disruption of the RPE cells. Therefore, the retinal layers were not atrophic in the presence of the 
nanostruc- tured ﬁbers, indicating no neuroretinal toxicity. Our OCT results were equivalent of those obtained by Hwang 
and co-workers (Hwang et al., 2013), who showed that a newly synthesized biodegradable andthermo-sensitive triblock 
copolymer consisting ofpoly(2-ethyl-2-oxazoline) (PEOz) and poly(e-caprolactone) (PCL) segments (PEOz-PCL-
PEOz, ECE), injected into the vitreous cavity of rabbit’s eye, did not induce neuroretinal toxicity, demon- strating its ocular 
safety. 
As described above, the inﬂammatory response within the eye involve the activation of resident macrophages and the 
recruit- ment of them and other inﬂammatory cells. Following activation,pro-inﬂammatory macrophages themselves produce 
a large number of mediators and cytokines including IL-1, IL-6, IL-12, TNF-a,and iNOS (Koh and DiPietro, 2011). 
Furthermore, in the injured regions of the eye, the activation and recruitment of micro- glial cells also occur, which damage 
the photoreceptors of the retina, probably through their secretion of pro-inﬂammatory mediators and cytotoxic factors, such 
as TNF-a, IL-1b and nitric oxide (Rutar et al., 2012). Therefore, the existence of an expressive number of activated 
macrophages and microglia within the eye after the implantation of the PCL nanoﬁbers could represent the installation of an 
inﬂammatory reaction in the ocular tissues, and consequently photoreceptor death and local retinal degeneration. However, 
the macrophages and microglia stained by IBA-1 were detected in extremely low quantity comparable to the control group, 
indicating that the nanostructured ﬁbers did not induce an inﬂammatory response within the eye by activating this kind of cel l 
population. 
Besides the activated and recruited macrophages and microglia produce pro-inﬂammatory cytokines, other retinal cells 
such as RPE cells are also capable of expressing those cytokines in the injured ocular tissues. The expression of these pro-
inﬂammatory mediators by retinal cells can lead to acute and chronic inﬂamma- tory processes associated to geographic 
atrophies inducing retinal degeneration. Therefore, it is mandatory to investigate and quan- tify the production of these 
substances by the retinal cells and cells from the fundus of the eye exposed to the PCL nanoﬁbers, which could trigger their 
expression leading to an inﬂammatory response within the eye. Accordingly to the RT-PCR results, the production of IL-
1band iNOS, classic pro-inﬂammatory cytokines, was extre- mely low for the cells in contact with the nanostructured ﬁbers 
when compared to the cells non-exposed to the biomaterial. The expression of TNF-afor the retinal cells is also associated to 
other types of pathophysiological activities including apoptotic cell death, cellular proliferation, differentiation and 
tumorogenesis. It has been previously reported that TNF-a induction mediated experimental retinal detachment inducing 
photoreceptor apopto- sis (Ding et al., 2009). Hence, the TNF-a production by the retinal cells was examined following the 
exposition to the PCL nanoﬁbers; however no signiﬁcant elevation of the production of the TNF-a was detected. Additionally, 
the ocular cells did not produce VEGF in a signiﬁcant manner. It is well documented that the over expres- sion of VEGF is 
believed to promote the progression of the choroi- dal neovascularization, inducing pathological angiogenesis (Ford and 
D’Amore, 2012). Finally, the basal level of pro-inﬂammatory cytokines extracted from the ocular cells of the posterior camera 
of the eye in contact with the PCL nanoﬁber indicated that this bio- material did not induce an inﬂammatory response within 
the eye, demonstrating its in vivoshort-term biocompatibility. 
Finally, the electrospun PCL nanoﬁbers were well tolerated byARPE-19 and MIO-M1 cells, demonstrating no cellular toxic 
response to the nanostructured mats. These biomaterials were also well tolerated and safety to the delicate tissues of the 
eye, since they did not elicit an observable cellular inﬁltration which could result in a severe inﬂammatory response, 
culminating in the degeneration of the retinal layers, and consequently, the loss of the visual function. Our excellent in vitro 
and in vivo results favor its intraocular application as delivery vehicle for controlled release of therapeutic agents to treat the 
pathologies of the posterior seg- ment of the eye.5. Conclusion 
In this work, electrospun PCL nanoﬁber randomly distributed was developed. The exposition of the polymeric 
nanostructured material to the ARPE-19 and MIO-M1 cells did not exert cytotoxic effects on the cell phenotype or cell 
functions, indicating its in vitro biocompatibility. Furthermore, the absence of microglia and macrophage activation, combined 
with the observed lack of inﬁl- trate inﬂammatory cells and low expression of cytokines in the ocular tissues suggested that 
there were no inﬂammatory response, hemorrhage and neovascularization within the eye exposed to the PCL nanoﬁber, 
demonstrating its in vivo biocom- patibility. Considering that the PCL nanoﬁber did not provide the adhesion ofARPE-
19 and MIO-M1 cells due to its hydrophobic sur- face, its applicability as ocular support was compromised. However, as the 
biocompatibility was demonstrated, it was sug- gested the potential use this biomaterial as a carrier for controlled and 
prolonged release of the synthetic drogues and bioactive sub- stances aiming the treatment of intraocular diseases. 
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